Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Neuro-Oncology|March 11, 2024
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO groupNorbert Galldiks, Timothy J Kaufmann, Philipp Vollmuth, et al.
Journal of Neuro-Oncology|October 2, 2015
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)Giuseppe Lombardi, Andrea Pace, Francesco Pasqualetti, et al.
Neurosurgery|April 21, 2025
Is FLAIRectomy Directly Correlated with Prolonged Survival in Glioblastoma? A Prospective National Multicenter Study on Correlation Between Extent of Tumor Resection and Clinical OutcomeFrancesco Certo, Alessandro Pluchino, Andrea Maugeri, et al.
The Lancet. Oncology|December 8, 2018
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trialGiuseppe Lombardi, Gian Luca De Salvo, Alba Ariela Brandes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2017
Prognostic value of molecular and imaging biomarkers in patients with supratentorial gliomaEgesta Lopci, Marco Riva, Laura Olivari, et al.
Neuro-Oncology|October 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1Martin J van den Bent, Enrico Franceschi, Mehdi Touat, et al.
Cancers|May 28, 2022
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter StudyMario Caccese, Matteo Simonelli, Veronica Villani, et al.
Neuro-Oncology Practice|July 15, 2024
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectivesFlorien Boele, Lena Rosenlund, Sara Nordentoft, et al.
Neurology|June 16, 2026
Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 TumorsFrancesco Bruno, Edoardo Pronello, Luca Bertero, et al.
The Lancet. Oncology|June 9, 2017
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with gliomaAndrea Pace, Linda Dirven, Johan A F Koekkoek, et al.
Pageof 19